R. Hilker‐Roggendorf

发表

Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters?

H. Braak, H. Huppertz, D. Berg, 2019, Human brain mapping.

Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease

J. Schulz, D. Berg, S. Baudrexel, 2021, Neurobiology of Aging.

Comparative analysis of machine learning algorithms for multi-syndrome classification of neurodegenerative syndromes

Sebastian Niehaus, Leonie Lampe, Alberto Merola, 2021, Alzheimer's Research & Therapy.

Evaluation of brain ageing: a quantitative longitudinal MRI study over 7 years

R. Deichmann, J. Klein, H. Steinmetz, 2017, European Radiology.

Cognitive decline in Parkinson’s disease: the impact of the motor phenotype on cognition

G. Deuschl, J. Schulz, A. Spottke, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

Role of dopamine agonists in Parkinson's disease therapy

D. Weise, C. Buhmann, T. Müller, 2023, Journal of Neural Transmission.

Long-Term Cognitive Decline Related to the Motor Phenotype in Parkinson's Disease.

G. Deuschl, A. Spottke, D. Berg, 2022, Journal of Parkinson's disease.

Structural brain signature of cognitive decline in Parkinson’s disease: DTI-based evidence from the LANDSCAPE study

D. Berg, S. Baudrexel, E. Kalbe, 2019, Therapeutic advances in neurological disorders.

Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD).

J. Schulz, A. Spottke, D. Berg, 2018, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Psychometric properties of the apathy evaluation scale in patients with Parkinson's disease

A. Spottke, S. Baudrexel, K. Witt, 2017, International journal of methods in psychiatric research.

A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study.

J. Schulz, K. Witt, E. Kalbe, 2021, Parkinsonism & related disorders.

Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessments

F. Jessen, W. Maier, J. Schulz, 2021, Alzheimer's & dementia.

Mid- and late-life lifestyle activities as main drivers of general and domain-specific cognitive reserve in individuals with Parkinson’s disease: cross-sectional and longitudinal evidence from the LANDSCAPE study

B. Mollenhauer, K. Reetz, I. Liepelt-Scarfone, 2024, Journal of neurology.